SARS-CoV-2 3CLpro-IN-7

Biorbyt

SARS-CoV-2 3CLpro-IN-7

10

Research Use Only

98.00%

C24H17ClN2O6

464.85

SARS-CoV-2 3CLpro-IN-7 is a reversible covalent inhibitor of the SARS-CoV-2 3CL protease, with an inhibitory concentration (IC50) of 1.4 microM.

C(=C\C1=CC=C(Cl)C=C1)(\NC(=O)C2=CC=CC=C2)/C(OCC(=O)C3=CC=C(N(=O)=O)C=C3)=O

-20°C

12352200